Overactive bladder (OAB) afflicts hundreds of millions of adults worldwide, and an effective if underused third-line treatment is neuromodulation. The longtime market-dominant devices, Medtronic PLC
Deep Brain Innovations, a company created by commercialization firm NDI Medical LLC , debuted at the Neurotech Investing and Partnering Conference in San Francisco May 24, with a novel algorithm fo
As one of the largest and fastest growing segments of the worldwide medical device market, neuromodulation devices are poised to more than double in revenues over the next decade. Although advances in
The neurostimulation market is becoming electric for many large companies looking for major growth opportunities. Worth $1.3 billion in the US in 2009, the neurostimulation market is expected to enjoy